Purpose To profile the characteristic and prognostic implications of venous thromboembolism (VTE) in Chinese ovarian clear cell carcinoma (CCC) patients. Methods We identified all of the cases between 2000 and 2012 by searching our institutional Ovarian CCC Database. A comprehensive review of the medical documentation was performed to collect relevant data. Kaplan-Meier models and Cox regression were employed for survival analysis. Results Of the 227 patients, 33 (14.5%) experienced VTE events. There was no significant differ-ence between VTE and non-VTE group patients regarding age, serum cancer antigen 125 or tumor size. The optimal cytoreduction rate was higher in patients without VTE (70.1%) than in those with VTE (51.5%). VTE events we...
<p>*Chi-square test and parametric student <i>t</i> test.</p><p>Abbreviations: CCC, clear cell carci...
A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment...
Background The prognosis of patients with cancer‐venous thromboembolism (VTE) is not well known beca...
To profile the characteristic and prognostic implications of venous thromboembolism (VTE) in Chinese...
ObjectivesTo determine the impact of venous thromboembolism (VTE) during primary treatment of ovaria...
Objective: Venous thromboembolism (VTE) is a life-threatening complication that often occurs in ovar...
Abstract Background Venous thromboembolism (VTE) is associated with ovarian cancer and may impact th...
The prevalence of venous thromboembolism (VTE) in ovarian cancer during first-line chemotherapy (CHT...
<p>Abbreviations: VTE, venous thromboembolism; DVT, deep vein thrombosis; PE, pulmonary embolism.</p...
BACKGROUND. Venous thromboembolism (VTE) is associated with ovarian cancer and may impact the progno...
Objectives To compare the clinicopathologic features and prognosis of Chinese patients with ovarian ...
Background: Thrombotic events are common in cancer patients and have been associated with an adverse...
Background: We compared survival outcomes and risk of venous thromboembolism (VTE) among patients wi...
Background: Venous thromboembolism (VTE) is a clinically significant complication that is well docum...
To compare the clinical outcomes of Taiwanese patients with ovarian clear cell carcinomas (CCCs) and...
<p>*Chi-square test and parametric student <i>t</i> test.</p><p>Abbreviations: CCC, clear cell carci...
A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment...
Background The prognosis of patients with cancer‐venous thromboembolism (VTE) is not well known beca...
To profile the characteristic and prognostic implications of venous thromboembolism (VTE) in Chinese...
ObjectivesTo determine the impact of venous thromboembolism (VTE) during primary treatment of ovaria...
Objective: Venous thromboembolism (VTE) is a life-threatening complication that often occurs in ovar...
Abstract Background Venous thromboembolism (VTE) is associated with ovarian cancer and may impact th...
The prevalence of venous thromboembolism (VTE) in ovarian cancer during first-line chemotherapy (CHT...
<p>Abbreviations: VTE, venous thromboembolism; DVT, deep vein thrombosis; PE, pulmonary embolism.</p...
BACKGROUND. Venous thromboembolism (VTE) is associated with ovarian cancer and may impact the progno...
Objectives To compare the clinicopathologic features and prognosis of Chinese patients with ovarian ...
Background: Thrombotic events are common in cancer patients and have been associated with an adverse...
Background: We compared survival outcomes and risk of venous thromboembolism (VTE) among patients wi...
Background: Venous thromboembolism (VTE) is a clinically significant complication that is well docum...
To compare the clinical outcomes of Taiwanese patients with ovarian clear cell carcinomas (CCCs) and...
<p>*Chi-square test and parametric student <i>t</i> test.</p><p>Abbreviations: CCC, clear cell carci...
A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment...
Background The prognosis of patients with cancer‐venous thromboembolism (VTE) is not well known beca...